Última Hora: "CP instala radares para medir lentidão dos carros nos acessos a Lisboa e Porto - Observador" Mon, 22 Jan 2018 10:33:14 GMT    ""Ronaldo da economia marca logo golo" e pede à Grécia rapidez no ajustamento - Diário de Notícias - Lisboa" Tue, 23 Jan 2018 00:18:06 GMT    "ADSE está disponível para pagar mais a privados, mas exige revisão de preços - Expresso" Tue, 23 Jan 2018 08:15:27 GMT   "This RSS feed URL is deprecated" Tue, 23 Jan 2018 12:43:39 GMT    "Pestana Hotel Group promove roadshow de recrutamento - Turisver" Tue, 23 Jan 2018 11:01:00 GMT    "Mercadona está a contratar 60 trabalhadores na região Norte - Expresso" Tue, 23 Jan 2018 11:20:00 GMT    "Os portugueses dizem-se bem-comportados ao volante - Visão" Tue, 23 Jan 2018 08:17:00 GMT    "Musk indexa salário à prestação da Tesla e deixa de ter remuneração garantida - Jornal de Negócios - Portugal" Tue, 23 Jan 2018 11:08:00 GMT    "Mais de 400 mil consumidores recorrem à Deco em 2017 com telecomunicações a liderar queixas - Expresso" Tue, 23 Jan 2018 08:00:00 GMT    "Luz Saúde compra a Idealmed - Expresso" Tue, 23 Jan 2018 08:44:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma. Dr. Abella ...

e mais »

VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors
GlobeNewswire (press release)
From February 2000 to September 2003 Mr. Hastings served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. Prior to his employment with ArQule, Mr. Hastings was Vice President and Corporate Controller at Genzyme Inc., and Director ...

e mais »

BioClin Therapeutics ernennt Graeme Currie, Ph.D., zum Chief Operating Officer ...
OnVista
Dr. Currie kann auf über 25 Jahre Erfahrung sowohl bei Pharma- als auch bei Biotechnologieunternehmen verweisen. Er hatte leitende Führungsrollen bei Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. und PDL Biopharma inne. Dr ...

e mais »

ArTara Therapeutics Announces Addition of Randall Marshall, MD as Chief Medical Officer
Business Wire (press release)
Prior to joining ArTara, Dr. Marshall led Retrophin, Inc.'s development of fosmetpantotenate, a replacement therapy for PKAN, an ultra-rare neurodegenerative disease. Under Dr. Marshall's leadership the program moved from first-in-man to pivotal trial ...

e mais »

Sleeping Pills ? Global Strategic Business Report
satPRnews (press release)
The report profiles 34 companies including many key and niche players such as Actelion Pharmaceuticals Ltd., Abbott India Limited, Apotex Inc., Aurobindo Pharma Limited, Caraco Pharmaceutical Laboratories, Ltd., Dr. Reddy's Laboratories Limited, H ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
... (USA), Inc. since September 2016, where he was instrumental in building the U.S. operations to support the company's regulatory and commercial strategy. Prior to joining Santhera U.S., Todd served as Executive Vice President and Chief Commercial ...

e mais »

Global Loratadine Market Trends Forecast Analysis by Manufacturers, Regions, Type and Application 2022
MilTech
Loratadine Market Report covers the present scenario and the growth prospects of the Loratadine Industry for 2017-2022. Loratadine Market report analyses the industry potential for each geographical region based on the growth rate, macroeconomic ...

e mais »

Desloratadine Market: Development, Growth, Trends, Demand, Share, Analysis and Forecast 2022
MilTech
Desloratadine Market Segment by Manufacturers: ? Pfizer,Teva,Wante Pharmaceutical, Novartis India Limited, Mylan,Sepracor,Sandoz,Apollo Pharmaceuticals,GSK,Mayne Pharma Inc and many more. Global Desloratadine market report also presents the ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
Prior to that , he held roles as Executive Vice President and Chief Administrative and Legal Officer at Inspire Pharmaceuticals Inc., where he oversaw all matters related to legal, quality and compliance, corporate development and licensing and ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Xencor (XNCR) Names Richard Ranieri to Board
StreetInsider.com
Mr. Ranieri has more than twenty years of senior level biopharma human resources leadership and currently serves as executive vice president of human resources and corporate affairs at BioMarin, where he manages and directs human resources worldwide ...

e mais »

Minerva Neurosciences Names Richard Russell President
GlobeNewswire (press release)
He then served as President and Chief Executive Officer of Stallergenes Greer, Inc., the North American subsidiary of Stallergenes Greer, PLC. Previously, Mr. Russell was Executive Vice President and Chief Commercial Officer at Sunovion (formerly ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
... Relations and Corporate Communications at HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies for advanced heart failure, which was acquired by Medtronic plc. Prior to HeartWare, Ms ...

e mais »

Law360

Health Hires: Holland & Knight, EBG, Quarles, Ciitizen
Law360
Before that, he was in-house at Sepracor, now known as Sunovion Pharmaceuticals, and Kos Pharmaceuticals. He helped create both companies' compliance programs, the firm said. Earlier, he directed litigation at Schering-Plough Corp. and served as an ...


Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by Dainippon ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters